Response to regulatory stringency: the case of antipsychotic medication use in nursing homes.

Department of Economics and Scripps Gerontology Center, Miami University, Oxford, OH 45056, USA.
Health Economics (Impact Factor: 2.14). 08/2012; 21(8):977-93. DOI: 10.1002/hec.1775
Source: PubMed

ABSTRACT This paper studies the impact of regulatory stringency, as measured by the statewide deficiency citation rate over the past year, on the quality of care provided in a national sample of nursing homes from 2000 to 2005. The quality measure used is the proportion of residents who are using antipsychotic medication. Although the changing case-mix of nursing home residents accounts for some of the increase in the use of antipsychotics, we find that the use of antipsychotics by nursing homes is responsive to state regulatory enforcement in a manner consistent with the multitasking incentive problem. Specifically, the effect of the regulations is dependent on the degree of complementarity between the regulatory deficiency and the use of antipsychotics.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The paper by Kleijer and colleagues (2014) in this issue of International Psychogeriatrics describes factors that may influence antipsychotic drug (APD) prescribing rates in nursing homes in several countries. The authors conclude that the large variability is only partly explained by differences in resident characteristics, and that it is associated with certain facility characteristics such as bed size and urban/rural location. They also identify the likelihood that differences in physician prescribing patterns or facility prescribing culture may influence APD prescribing rates, as has been found in previous studies (Briesacher et al., 2005; Chen et al., 2010).
    International Psychogeriatrics 03/2014; 26(3):361-2. DOI:10.1017/S1041610213002597 · 1.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives To describe the rationales that providers and family members cite for the use of antipsychotic medications in people with dementia living in nursing homes (NHs).DesignQualitative, descriptive study.SettingTwenty-six medium-sized and large facilities in five Centers for Medicare and Medicaid Services regions.ParticipantsIndividuals diagnosed with dementia who received an antipsychotic medication.MeasurementsData were collected from medical record abstraction and interviews with prescribers, administrators, direct care providers, and family members. Textual data from medical record abstraction and responses to open-ended interview questions were analyzed using directed content analysis techniques. A coding scheme was developed, and coded reasons for antipsychotic prescribing were summarized across all sources.ResultsMajor categories of reasons for use of antipsychotic medications in the 204 NH residents in the study sample were behavioral (n = 171), psychiatric (n = 159), emotional states (n = 105), and cognitive diagnoses or symptoms (n = 114). The most common behavioral reasons identified were verbal (n = 91) and physical (n = 85) aggression. For the psychiatric category, psychosis (n = 95) was most frequently described. Anger (n = 93) and sadness (n = 20) were the most common emotional states cited.Conclusion The rationale for use of antipsychotic drug therapy frequently relates to a wide variety of indications for which these drugs are not approved and for which evidence of efficacy is lacking. These findings have implications for clinical practice and policy.
    Journal of the American Geriatrics Society 01/2015; DOI:10.1111/jgs.13230 · 4.22 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives To assess whether reductions in physical restraint use associated with quality reporting may have had the unintended consequence of increasing antipsychotic use in nursing home (NH) residents with severe cognitive impairment. DesignRetrospective analysis of NH clinical assessment data from 1999 to 2008 comparing NHs subject to public reporting of physical restraints with nonreporting NHs. SettingMedicare- and Medicaid-certified NHs in the United States. ParticipantsObservations (N = 3.9 million) on 809,645 residents with severe cognitive impairment in 4,258 NHs in six states. InterventionPublic reporting of physical restraint use rates. MeasurementsUse of physical restraints and antipsychotic medications. ResultsPhysical restraint use declined significantly from 1999 to 2008 in NH residents with severe cognitive impairment. The decline was larger in NHs that were subject to reporting of restraints than in those that were not (–8.3 vs –3.3 percentage points, P < .001). Correspondingly, antipsychotic use in the same residents increased more in NHs that were subject to public reporting (4.5 vs 2.9 percentage points, P < .001). Approximately 36% of the increase in antipsychotic use may be attributable to public reporting of physical restraints. Conclusion This analysis suggests that public reporting of physical restraint use had the unintended consequence of increasing use of antipsychotics in NH residents with severe cognitive impairment.
    Journal of the American Geriatrics Society 03/2014; DOI:10.1111/jgs.12711 · 4.22 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014